# ePRO for Adjuvant Therapy of Colorectal Adenocarcinoma

> **NCT04069455** · NA · UNKNOWN · sponsor: **Zhejiang University** · enrollment: 270 (estimated)

## Conditions studied

- Colorectal Carcinoma

## Interventions

- **OTHER:** Electronic Patients Reported Outcomes

## Key facts

- **NCT ID:** NCT04069455
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-01
- **Primary completion:** 2021-10-01
- **Final completion:** 2024-09-30
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2021-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04069455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04069455, "ePRO for Adjuvant Therapy of Colorectal Adenocarcinoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04069455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*